Publicaciones científicas en Inglés. 2002

García Cosío F, Delpón E.
New antiarrhythmic drugs for atrial flutter and atrial fibrillation. A conceptual breakthrough at last?
Circulation 2002; 105:276-278

Ibarra M, Pérez-Vizcaíno F, Cogolludo A, Duarte J, Zaragoza-Arnáez F, López.López JG, Tamargo J.
Cardiovascular effects of isorhamnetin and quercetin in isolated rat and porcine vascular smooth muscle and isolated rat atria.
Planta Medica. 2002; 68: 307-310.

Pérez-Vizcaíno F, Ibarra M, Cogolludo AL, Duarte J, Zaragozá-Arnáez F, Moreno L, López-López G, Tamargo J.
Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries.
J Pharmacol Exp Ther 2002; 302: 66-72.

Duarte J, Jiménez R, O'Valle F, Galisteo M, Pérez-Palencia R, Vargas F, Pérez-Vizcaíno F, Zarzuelo A, Tamargo J.
Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats.
J Hypertens 2002; 20: 1843-1854.

Barrios V, Navarro A, Esteras A, Luque M, Romero J, Tamargo J, Prieto L, Carrasco JL, Herranz I, Navarro-Cid J, Ruilope LM.
Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE Study. Eficacia de lercanidipino y su perfil de seguridad.
Blood Press 2002; 11: 95-100.

Pérez-Vizcaíno F, López-López JG, Santiago R, Cogolludo A, Zaragoza-Arnáez F, Alonso MJ, Salaíces M, Tamargo J.
Postnatal maturation in nitric oxide-induced pulmonary artery relaxation involving cyclooxygenase-1 activity.
Am J Physiol. 2002; 283: L839-L848.

Caballero R, Moreno I, González T, Valenzuela C, Tamargo J, Delpón E.
Putative binding site for benzocaine on a human cardiac cloned channel (Kv1.5).
Cardiovasc Res. 2002, 56: 104-117.

Banegas JR, Rodríguez-Artalejo F, Ruilope LM, Graciani A, Luque M, De la Cruz-Troca JJ , García-Robles R, Tamargo J, Rey-Calero J.
Hypertension magnitude and management in the elderly population of Spain.
J Hypertens 2002; 20: 2157-2164.

González T, Navarro-Polanco R, Longobardo M, Caballero R, Moreno I, Delpón E, Tamargo J, Tamkun MM, Valenzuela C.
Assembly with the Kv b 1.3 subunit modulates drug block of hKv1.5 channels.
Mol Pharmacol 2002; 62: 1456-1463.

Tamargo J.
Does increased heart rate represent a similar risk factor in both genders?.
Medicographia No. 72. 2002; 24: 231-236.

González T, Arias C, Caballero R, Moreno I, Delpón E, Tamargo J, Valenzuela C.
Effects of levobupivacaine, ropivacaine, and bupivacaine on HERG channels: stereoselective bupivacaine block.
Br J Pharmacol 2002; 137: 1269-1279

Weerapura M, Nattel S, Chartier D, Caballero R, Herbert T
A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current
J Physiol 2002; 540: 15-27